BioC (Q88QW9, PP_0365) in Pseudomonas putida KT2440 — Malonyl-[acyl-carrier-protein] O-Methyltransferase

Gene: bioC | Ordered locus: PP_0365 | UniProt: Q88QW9
Protein: Malonyl-[acyl-carrier protein] O-methyltransferase (Malonyl-ACP O-methyltransferase)
EC: 2.1.1.197 | Length: 272 aa | Organism: Pseudomonas putida (strain ATCC 47054 / DSM 6125 / KT2440)

Summary

BioC (UniProt Q88QW9; ordered locus PP_0365) of Pseudomonas putida KT2440 is a soluble, cytoplasmic, S-adenosyl-L-methionine (SAM)-dependent Class I methyltransferase that catalyzes the committed initiating step of the biotin pimelate moiety. Its curated catalytic activity (EC 2.1.1.197, RHEA:17105) is: malonyl-[ACP] + S-adenosyl-L-methionine → malonyl-[ACP] methyl ester + S-adenosyl-L-homocysteine. By methyl-esterifying the free ω-carboxyl group of a malonyl-thioester, BioC "disguises" an atypical dicarboxylic substrate so that it is accepted by the type II fatty acid synthase (FAS II) machinery, which normally rejects such substrates. This single chemical modification repurposes a fatty-acid-like elongation pathway to build the seven-carbon α,ω-dicarboxylic pimelate backbone of biotin.

The functional assignment for the P. putida protein rests on strong orthology to the biochemically characterized Escherichia coli BioC. Pairwise global alignment of Q88QW9 against the E. coli enzyme (P12999) gives 49.4% sequence identity, the SAM-binding glycine-rich Motif I (LDLGSGTG) is conserved at position 58, and the protein carries the Methyltransferase type 11 domain (PF08241) within the Class I Rossmann-fold SAM-dependent methyltransferase superfamily. Annotation is propagated by HAMAP rule MF_00835. Critically, bioC (PP_0365) sits within an intact, syntenic biotin gene cluster (PP_0362–PP_0366: bioB, bioF, bioH, bioC, bioD), immediately flanked by its physiological esterase partner bioH (PP_0364) and by bioD (PP_0366). This genomic context strongly supports the canonical BioC–BioH pimelate-synthesis route rather than one of the several non-orthologous bypasses found in other bacteria.

BioC performs its function in the cytoplasm. Sequence and hydropathy analysis of the 272-residue protein reveals no signal peptide, no transmembrane or intramembrane segment, and no lipidation site; the overall GRAVY value of −0.034 and the absence of any membrane-spanning hydrophobic window are consistent with a fully soluble enzyme that acts on the soluble acyl-carrier-protein-tethered substrate pool in the cytosol, in concert with the soluble FAS II enzymes and downstream biotin-synthesis proteins.

Key Findings

F001 — BioC is a SAM-dependent malonyl-ACP O-methyltransferase (EC 2.1.1.197)

BioC (Q88QW9, PP_0365) is a 272-amino-acid protein encoded by the bioC/PP_0365 gene of P. putida KT2440. Its curated catalytic activity, deposited as RHEA:17105, is the SAM-dependent methylation of a malonyl-thioester:

malonyl-[ACP] + S-adenosyl-L-methionine = malonyl-[ACP] methyl ester + S-adenosyl-L-homocysteine

The enzyme contains a Methyltransferase type 11 domain (residues ~58–152; Pfam PF08241) embedded within the Class I Rossmann-fold SAM-dependent methyltransferase superfamily. The methyl group is transferred from SAM to the free ω-carboxyl group of the malonyl-thioester, generating a methyl ester and releasing S-adenosyl-L-homocysteine (SAH) as the demethylated cofactor product. This chemistry was mechanistically demonstrated in E. coli by Lin, Hanson & Cronan (2010) and has been independently confirmed for BioC enzymes from other bacteria, including the Acinetobacter baumannii and Klebsiella pneumoniae isoenzymes characterized in 2024, both of which act as malonyl-ACP methyltransferases that initiate biotin synthesis.

The defining statement of the reaction comes from the E. coli work: "the omega-carboxyl group of a malonyl-thioester is methylated by BioC, which allows recognition of this atypical substrate by the fatty acid synthetic enzymes" [PMID: 20693992]. The 2024 ESKAPE study reinforces the general validity of this assignment across pathogens: "two BioC isoenzymes (AbBioC for A. baumannii and KpBioC for K. pneumoniae) that act as malonyl-ACP methyltransferase and initiate bi[otin synthesis]" [PMID: 39705367]. For the P. putida protein the assignment is by orthology (see F003), with the reaction curated in UniProt via HAMAP rule MF_00835.

F002 — BioC initiates the pimelate moiety by disguising malonyl-thioester for FAS II elongation

The biological purpose of BioC's methylation reaction is to launch the pimelate (C7 α,ω-dicarboxylic acid) moiety of biotin. Genetic and in vitro reconstitution experiments in E. coli established that the pimeloyl moiety is built by a modified fatty acid synthetic pathway. BioC methyl-esterifies the ω-carboxyl of a malonyl-thioester; the resulting methyl ester substitutes for the usual acetyl thioester primer and enters FAS. It then undergoes two reiterations of the fatty acid elongation cycle to yield pimeloyl-ACP methyl ester, which is subsequently hydrolyzed to pimeloyl-ACP plus methanol by BioH.

As the E. coli study describes: "The malonyl-thioester methyl ester enters fatty acid synthesis as the primer and undergoes two reiterations of the fatty acid elongation cycle to give pimeloyl-acyl carrier protein (ACP) methyl ester, which is hydrolyzed to pimeloyl-ACP and methanol by BioH" [PMID: 20693992]. A reconstituted desthiobiotin-synthesis system confirmed that malonyl-ACP is converted to pimeloyl-ACP via the pimeloyl-ACP methyl ester intermediate with the aid of FAS II: "make pimeloyl-acyl carrier protein (ACP) from the substrate malonyl-ACP with the aid of the FAS II pathway, through the expected pimeloyl-ACP methyl ester intermediate" [PMID: 30915508].

The strategic logic is elegant: the methyl ester acts as a chemical "disguise" that masks the extra carboxyl group of the dicarboxylic precursor, so that the strictly-specific FAS II enzymes — which would otherwise reject a charged, polar ω-carboxyl — accept and elongate it as though it were an ordinary fatty acyl chain. Methylation at the start (BioC) and demethylation at the end (BioH) bracket the FAS II elongation and control chain length. This places BioC firmly in the cofactor biosynthesis; biotin biosynthesis pathway (UniProt pathway annotation).

F003 — bioC (PP_0365) sits in an intact, syntenic biotin gene cluster with its BioH esterase partner

A survey of the P. putida KT2440 genome shows the biotin genes are organized as a contiguous cluster at the PP_0362–PP_0366 locus:

bioC is immediately flanked by bioH (PP_0364) — its physiological downstream esterase partner — and by bioD (PP_0366). The co-localization of bioC and bioH in the same cluster is a strong genomic signature of the canonical BioC-methylation route. bioA (PP_4984) lies elsewhere in the genome, a common arrangement in Pseudomonads.

The orthology evidence for the functional call is quantitative. Pairwise global alignment of Q88QW9 against the biochemically characterized E. coli BioC (P12999) gives 49.4% identity (118/239 aligned columns), and the SAM-binding glycine-rich Motif I (LDLGSGTG) is conserved at position 58 — the hallmark of a functional Class I methyltransferase SAM-binding pocket. Together, sequence identity, motif conservation, and genomic synteny establish that PP_0365 is a bona fide bioC ortholog operating in the canonical route.

F004 — BioC's methyl acceptor is malonyl-ACP; the BioC–BioH route is one of several convergent pimelate strategies

Multiple reconstitution studies specify malonyl-ACP as the BioC methyl-acceptor substrate that is converted to pimeloyl-ACP via the pimeloyl-ACP methyl ester intermediate with FAS II [PMID: 30915508; PMID: 39705367]. The reaction is curated in UniProt/Rhea as malonyl-[ACP] + SAM → malonyl-[ACP] methyl ester + SAH (RHEA:17105). (In E. coli, malonyl-CoA can also serve as a substrate in vitro, with the ACP-tethered species being the physiological acceptor for downstream FAS II elongation.)

Importantly, the BioC–BioH strategy is only one of several convergent, non-orthologous solutions bacteria use to build pimeloyl-ACP. Alternative routes do not use BioC:

• BioZ route: BioZ is a domesticated β-ketoacyl-ACP synthase III that condenses glutaryl-CoA (or glutaryl-ACP) with malonyl-ACP to give 5-keto-pimeloyl-ACP — a completely different chemistry that bypasses BioC methylation entirely: "BioZ catalyzes the condensation of glutaryl-CoA (or ACP) with malonyl-ACP to give 5'-keto-pimeloyl ACP" [PMID: 33824341].
• BioW/BioI-type routes exist in yet other lineages.
• Downstream, the esterase step can be performed by evolutionarily distinct enzymes: BioH (the E. coli paradigm, present in P. putida), BioG, BioK, or the Helicobacter-restricted BioV — all catalyzing a common reaction with unrelated protein scaffolds [PMID: 23152908; PMID: 26868423].

In P. putida KT2440, the presence of both bona fide bioC (PP_0365) and bioH (PP_0364) unambiguously indicates the canonical BioC-methylation route rather than any of these bypasses. This comparative context sharpens the specific role of the P. putida enzyme: it is the SAM-dependent methyltransferase, not a condensing enzyme, and its output feeds a BioH esterase rather than a BioG/BioK/BioV alternative.

F005 — BioC is a soluble cytoplasmic enzyme with no signal peptide or transmembrane segment

Sequence and feature analysis of the 272-residue Q88QW9 protein localizes BioC to the cytoplasm. UniProt annotates only a Domain feature (Methyltransferase type 11) and records no signal peptide, no transmembrane helix, no intramembrane segment, and no lipidation site. A Kyte-Doolittle hydropathy scan (window 19) gives a maximum windowed hydropathy of 1.25, below the ~1.6 threshold indicative of a membrane-spanning helix — i.e., no predicted transmembrane region. The overall GRAVY value is −0.034, consistent with a hydrophilic, soluble protein. The N-terminus (MTDLSRPTLPGALPDKRQ…) lacks a cleavable signal-peptide hydrophobic core.

This localization is exactly what the biochemistry requires: BioC acts on ACP-tethered malonyl-thioesters, which are soluble cytosolic species processed by the equally soluble FAS II enzymes and the downstream biotin-synthesis proteins (BioF, BioA, BioD, BioB). All of these steps occur in the cytoplasm, and BioC is fully compatible with that compartment.

Mechanistic Model / Interpretation

BioC catalyzes the very first, committed step that diverts primary fatty-acid-synthesis building blocks into the biotin biosynthetic pathway. The mechanistic logic is a "methyl-on / methyl-off" disguise strategy that allows a specialized C7 dicarboxylic acid to be assembled by the general-purpose fatty acid synthase.

         SAM     SAH
          \       /
           \     /
   malonyl-ACP  ───────────► BioC ───────────►  malonyl-ACP methyl ester
   (free ω-COOH)          (PP_0365)              (ω-COOH now "disguised"
          EC 2.1.1.197            as a methyl ester)
                                          │
                                          │  enters FAS II
                                          │  as an atypical primer
                                          ▼
                          ── 2 cycles of FAS II elongation ──
                          (FabB/F, FabG, FabA/Z, FabI; malonyl-ACP)
                                          │
                                          ▼
                             pimeloyl-ACP methyl ester
                                          │
                                          │  BioH (PP_0364)
                                          │  esterase, EC 3.1.1.85
                                          │  (+ H2O → methanol)
                                          ▼
                                   pimeloyl-ACP
                                          │
                                          ▼
   BioF (PP_0363) ── + L-alanine ──► KAPA (AON)
   BioA (PP_4984) ── transamination ──► DAPA (DAN)
   BioD (PP_0366) ── + CO2/ATP ──► dethiobiotin
   BioB (PP_0362) ── + S ──► BIOTIN

The key conceptual points:

1. BioC is the "gate-opener." Without the methyl ester, FAS II would reject the malonyl species' extra carboxyl. Methylation makes the substrate look like an ordinary acyl primer, so the standard elongation cycle proceeds.
2. Chain-length control is bracketed by methylation/demethylation. BioC installs the methyl ester at the start; BioH removes it at exactly the right chain length (pimeloyl, C7), which both stops further elongation and hands off pimeloyl-ACP to the amino-transfer/ring-forming steps. This is why the two enzymes are functionally coupled and genomically co-located.
3. BioC defines the pathway's identity. The presence of bioC + bioH (rather than BioZ, BioW, or a BioG/BioK/BioV esterase) tells us P. putida uses the E. coli-type modified-FAS route. This is the single most informative diagnostic for the organism's pimelate strategy.
4. All chemistry is cytosolic. BioC, FAS II, BioH, and the downstream Bio enzymes are soluble and operate on soluble ACP-tethered intermediates in the cytoplasm.

The confidence level for the P. putida assignment is high but is fundamentally an orthology-based inference: the reaction has not been directly measured on the purified P. putida enzyme. However, 49% identity to a biochemically validated enzyme, a conserved SAM-binding motif, an intact syntenic operon, and consistency with a well-established, conserved pathway together make the assignment robust.

Evidence Base

Across the 9 papers reviewed, the mechanism of BioC (ω-carboxyl methylation of a malonyl-thioester to initiate a modified FAS route) is consistently supported, and no study challenges the core assignment. The primary source of uncertainty is not the mechanism but the fact that direct biochemistry has been done on E. coli and ESKAPE-pathogen orthologs rather than on the P. putida protein itself.

Limitations and Knowledge Gaps

1. No direct biochemical characterization of the P. putida enzyme. The catalytic activity, substrate specificity, and kinetics for Q88QW9 have not been measured experimentally. The assignment is by orthology (49% identity to E. coli BioC, conserved SAM-binding motif, HAMAP MF_00835) and genomic context. While robust, this is inference, not measurement.

2. No experimental structure. There is no crystal or cryo-EM structure of P. putida BioC; the Rossmann-fold/Methyltransferase type 11 architecture is inferred from family assignment. An AlphaFold model with confidence analysis of the SAM-binding pocket and catalytic residues would strengthen the structural picture.

3. Substrate form not directly confirmed for P. putida. Whether the physiological acceptor in P. putida is malonyl-ACP (versus malonyl-CoA) is inferred from the general FAS II mechanism; it has not been directly tested in this organism.

4. Regulation and expression context unstudied. Operon regulation (e.g., a BirA/biotin-repressor system), expression conditions, and metabolic flux control for the P. putida biotin cluster were not characterized in this investigation.

5. Localization is predicted, not observed. Cytoplasmic localization is inferred from the absence of a signal peptide/TM helix and hydropathy analysis, consistent with the biochemistry, but has not been experimentally verified for this protein.

Proposed Follow-up Experiments / Actions

1. Direct enzymatic assay of purified P. putida BioC. Express and purify Q88QW9, and measure SAM-dependent methylation of malonyl-ACP (and malonyl-CoA) by monitoring SAH production or methyl-ester formation. Determine kcat/Km and confirm substrate preference.

2. Genetic complementation. Test whether P. putida PP_0365 restores biotin prototrophy to an E. coli ΔbioC strain, the classic in vivo confirmation of function used for BioG/BioK/BioV orthologs.

3. In vitro reconstitution. Reconstitute pimeloyl-ACP synthesis from malonyl-ACP using purified P. putida BioC + FAS II + BioH (PP_0364), following the desthiobiotin-synthesis reconstitution approach [PMID: 30915508], to verify the full BioC→BioH handoff in this organism.

4. Structural determination / modeling. Solve or model (AlphaFold) the P. putida BioC structure; validate the SAM-binding pocket (Motif I LDLGSGTG at position 58) and identify the catalytic residue(s) that position the ω-carboxyl for methyl transfer.

5. Deletion phenotyping. Construct a PP_0365 knockout and assess biotin auxotrophy and rescue by exogenous biotin, pimelate, or pimeloyl-ACP methyl ester, confirming the committed-step role.

6. Comparative pathway confirmation. Bioinformatically confirm the absence of BioZ/BioW/BioG/BioK/BioV genes in P. putida KT2440, cementing that the canonical BioC–BioH route is the sole pimelate strategy in this strain.

Conclusion

BioC (Q88QW9, PP_0365) is the Pseudomonas putida KT2440 malonyl-[acyl-carrier-protein] O-methyltransferase (EC 2.1.1.197), a soluble cytoplasmic SAM-dependent Class I methyltransferase that catalyzes the committed first step of biotin's pimelate moiety. It methyl-esterifies the free ω-carboxyl of malonyl-ACP, disguising it so FAS II elongates it to pimeloyl-ACP methyl ester, which the adjacent BioH esterase (PP_0364) converts to pimeloyl-ACP feeding the BioF→BioA→BioD→BioB biotin ring-assembly steps. The assignment is supported by 49% identity to biochemically validated E. coli BioC, a conserved SAM-binding motif, HAMAP rule MF_00835, and an intact syntenic bioBFHCD operon — pending direct biochemical confirmation on the P. putida enzyme itself.

Artifacts

• OpenScientist final report
• OpenScientist final report

Citations

1. PMID:20693992
2. PMID:39705367
3. PMID:30915508
4. PMID:33824341
5. PMID:23152908
6. PMID:26868423
7. PMID:23045647
8. PMID:32117167
9. PMID:31085296